To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

PLANO, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced that its Board of Directors has authorized a share repurchase program of up to $200 million of the Company’s outstanding common stock. “This share repurchase program reflects the confidence of the Board and management in our strategy, financial position, and ability to generate strong free cash flows,” said Payman Khales, Int ...

Core Viewpoint - Raymond James has lowered the price target for Integer (ITGR) to $95 from $143 while maintaining an Outperform rating, following a 32% decline in stock price due to customer-related headwinds impacting 2026 organic growth [1] Group 1: Price Target and Rating - The price target for Integer (ITGR) has been reduced to $95 from $143 [1] - Raymond James continues to hold an Outperform rating on the shares despite the price target adjustment [1] Group 2: Stock Performance and Market Reaction - The stock experienced a significant drop of 32% after news of limitations from three customers affecting future growth [1] - The update regarding the price target and rating was unexpected for investors who were already cautious prior to the announcement [1] Group 3: Growth Outlook and Future Prospects - The company is facing headwinds that limit 2026 organic growth to low single digits (LSD) [1] - Despite current challenges, there is optimism for recovery starting in late 2026 due to a broad range of exposures and upcoming product launches [1]

Core Insights - Integer Holdings Corporation (NYSE: ITGR) was previously considered overvalued, but has since demonstrated solid share price returns, indicating a potential reevaluation of its market position [1]. Group 1 - Integer Holdings Corporation is highlighted as a leader in the investment group "Value In Corporate Events," which focuses on identifying opportunities in IPOs, mergers & acquisitions, and earnings reports [1]. - The investment group covers approximately 10 major corporate events each month, aiming to find the best investment opportunities for its members [1].

Core Insights - Integer Holdings Corporation (ITGR) reported adjusted earnings per share (EPS) of $1.79 for Q3 2025, reflecting a year-over-year increase of 25.2% and exceeding the Zacks Consensus Estimate by 6.6% [1][9] - The company generated revenues of $467.7 million in Q3 2025, marking an 8.4% increase year over year and surpassing the Zacks Consensus Estimate by 0.4% [2][9] - Despite strong quarterly results, ITGR shares fell over 30% due to concerns regarding slower revenue growth guidance for 2026 [9][13] Revenue Breakdown - Revenues from the Cardio and Vascular (C&V) segment reached $277.1 million, up 14.9% year over year, driven by new product ramps and strong customer demand [5] - The Cardiac Rhythm Management & Neuromodulation (CRM&N) segment reported revenues of $169.2 million, reflecting a 2.5% year-over-year increase [6] - Other Markets revenues totaled $21.4 million, down 15.5% year over year, attributed to the planned exit from Portable Medical [7] Margin and Expense Analysis - Gross profit for Q3 2025 was $126.2 million, an 8.2% increase year over year, with a gross margin of 26.9%, a slight contraction of 10 basis points [8][10] - Selling, general and administrative expenses rose to $50.5 million, up 12.6% year over year, while research and development costs decreased to $10.9 million, down 8.2% [10] Financial Position - At the end of Q3 2025, Integer Holdings had cash and cash equivalents of $58.9 million, up from $23.1 million at the end of Q2 2025, with total debt decreasing to $1.19 billion [11] 2025 Guidance - The company updated its 2025 revenue guidance to a range of $1,840 million to $1,854 million, indicating a 7-8% improvement from 2024, while adjusted EPS is expected to be between $6.29 and $6.43, reflecting a 19-21% increase [12]

Core Insights - Integer Holdings Corporation reported Q3 earnings of $1.79 per share, exceeding the analyst consensus estimate of $1.68 per share [1] - The company achieved quarterly sales of $467.691 million, surpassing the analyst consensus estimate of $466.452 million [1] Financial Performance - Sales increased by 8%, adjusted operating income rose by 14%, and adjusted EPS grew by 25% [2] - FY2025 adjusted EPS guidance was narrowed from $6.25-$6.51 to $6.29-$6.43, and sales guidance was cut from $1.850 billion-$1.876 billion to $1.840 billion-$1.854 billion [2] Stock Performance - Integer Holdings shares fell by 3.2% to $71.49 following the earnings announcement [3] - Analysts adjusted their price targets for Integer Holdings after the earnings report [3] Analyst Ratings - Citigroup downgraded Integer Holdings from Buy to Neutral, lowering the price target from $140 to $77 [5] - Wells Fargo downgraded the stock from Overweight to Equal-Weight, cutting the price target from $132 to $80 [5] - Keybanc maintained an Overweight rating but reduced the price target from $133 to $93 [5] - Benchmark downgraded Integer Holdings from Buy to Hold [5]

Core Viewpoint - Integer's stock experienced a significant decline of 32% on October 23, 2025, primarily due to updated financial projections indicating slower-than-expected product uptake, overshadowing otherwise strong Q3 earnings [1] Financial Performance - Integer's revenues increased by 9.6% over the last 12 months, rising from $1.6 billion to $1.8 billion, compared to a 5.1% growth for the S&P 500 [13] - The company recorded quarterly revenues of $476 million, an 11.4% increase from $428 million a year prior, while the S&P 500 saw a 6.2% increase [13] - Operating income for the past four quarters was $236 million, with a moderate operating margin of 13.1%, compared to 18.6% for the S&P 500 [13] - Net income stood at $83 million, indicating a poor net income margin of 4.6%, versus 12.7% for the S&P 500 [13] Valuation Metrics - Integer's price-to-sales (P/S) ratio is 1.4, compared to 3.2 for the S&P 500 [7] - The price-to-earnings (P/E) ratio is 31.3 against the benchmark's 24.2 [7] - The price-to-free cash flow (P/FCF) ratio is 21.5, slightly above the S&P 500's 21.1 [7] Financial Stability - Integer's balance sheet is described as fragile, with total debt of $1.3 billion and a market capitalization of $2.6 billion, leading to a moderate debt-to-equity ratio of 51.0% compared to 21.1% for the S&P 500 [9][13] - Cash and cash equivalents amount to $23 million of the total assets of $3.4 billion, resulting in a very poor cash-to-assets ratio of 0.7%, while the S&P 500 has a ratio of 7.0% [13] Resilience in Downturns - ITGR stock has historically performed worse than the S&P 500 during several downturns, indicating weak resilience [10] - The stock has experienced significant declines in past crises, including a 54.9% drop from July 2007 to May 2008, compared to a 56.8% decline for the S&P 500 [14] Overall Assessment - Integer's operational performance and financial condition are assessed as moderate, with strong growth but weak profitability and financial stability [15]

Core Viewpoint - Integer Holdings Corp. has experienced a significant decline in stock performance, reaching an all-time low due to lowered sales outlook for 2025 and anticipated operational challenges impacting margins in the coming years [1][3]. Financial Performance - The stock price fell to a 52-week low of $66.5 during intra-day trading, ultimately closing down 32.28% at $73.89 [2]. - For the third quarter, Integer reported a net income increase of 11.96%, amounting to $39.68 million compared to $35.44 million in the same period last year, with sales growing by 8.4% to $467.7 million from $431.4 million year-on-year [6]. Revised Outlook - The company now expects full-year 2025 sales growth to be between 7% and 8%, a decrease from the previous target of 8% to 9% [3]. - Operating income projections have been revised to $220 million to $226 million, reflecting a growth of 6% to 9% year-on-year, down from the earlier forecast of $232 million to $244 million, which represented an 11% to 17% growth [3]. - For 2026, sales are expected to either decline or grow by 2%, with organic sales anticipated to remain unchanged or increase by 4% [4]. Management Commentary - The President and CEO of Integer Holdings Corp. expressed confidence in the company's strategy and product development pipeline, projecting a return to 200 basis points above-market organic growth by 2027 despite current headwinds [5].

Leadership Transition - Integer Holdings Corporation has completed a planned leadership transition with Payman Khales assuming the role of President and CEO, succeeding Joseph Dziedzic who is retiring after eight years [1] - Joseph Dziedzic will continue to serve as an advisor until March 31, 2026, to ensure a smooth transition [1] Executive Background - Payman Khales joined Integer in 2018 as President of the Cardio & Vascular business, where he successfully doubled sales over seven years and improved service levels and profitability [2] - As Chief Operating Officer, Khales oversaw Integer's business units and global operations, enhancing the company's reputation as a strategic partner to medical device companies [2] Vision and Strategy - Khales expressed enthusiasm for the opportunities ahead, focusing on innovation, collaboration with customers, and delivering life-changing medical technologies [3] - He emphasized the importance of creating value through teamwork and leveraging the talents of Integer's associates [3] Company Overview - Integer Holdings Corporation is a leading global medical device contract development and manufacturing organization, serving markets such as cardiac rhythm management and neuromodulation [4] - The company is committed to enhancing patient lives by providing innovative, high-quality products and solutions, with brands including Greatbatch Medical and Lake Region Medical [4]

Group 1 - The article does not provide any specific content or key points related to a company or industry [1]